Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01336023

Public ClinicalTrials.gov record NCT01336023. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of this trial is to compare the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin degludec (IDeg) and liraglutide (Lira) in subjects with type 2 diabetes. Subjects are to continue their pre-trial treatment with metformin or metformin + pioglitazone throughout the entire trial.

Study identification

NCT ID
NCT01336023
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,663 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 23, 2011 (Actual)
Primary completion
May 24, 2012 (Actual)
Completion
Nov 22, 2012 (Actual)
Last update posted
Feb 19, 2018

2011 – 2012

United States locations

U.S. sites
146
U.S. states
31
U.S. cities
129
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35216 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Bermuda Dunes California 92203 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Encino California 91436 —
Novo Nordisk Investigational Site Fair Oaks California 95628 —
Novo Nordisk Investigational Site Fresno California 93702 —
Novo Nordisk Investigational Site Greenbrae California 94904 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site Monterey California 93940 —
Novo Nordisk Investigational Site Orange California 92868 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site San Diego California 92117 —
Novo Nordisk Investigational Site San Diego California 92161-0002 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site Santa Barbara California 93105 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Valencia California 91355 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80910 —
Novo Nordisk Investigational Site Denver Colorado 80209 —
Novo Nordisk Investigational Site Golden Colorado 80401 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Newark Delaware 19713 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Delray Beach Florida 33484 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Jacksonville Florida 32258 —
Novo Nordisk Investigational Site Kissimmee Florida 34741 —
Novo Nordisk Investigational Site Melbourne Florida 32934 —
Novo Nordisk Investigational Site Miami Florida 33135 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Orlando Florida 32804 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33027 —
Novo Nordisk Investigational Site Tampa Florida 33603 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Columbus Georgia 31909 —
Novo Nordisk Investigational Site Conyers Georgia 30094-5965 —
Novo Nordisk Investigational Site Decatur Georgia 30035 —
Novo Nordisk Investigational Site Lawrenceville Georgia 30046 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Woodstock Georgia 30189-4255 —
Novo Nordisk Investigational Site Meridian Idaho 83646 —
Novo Nordisk Investigational Site Nampa Idaho 83686-6011 —
Novo Nordisk Investigational Site Avon Illinois 46123 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Gurnee Illinois 60031 —
Novo Nordisk Investigational Site O'Fallon Illinois 62246 —
Novo Nordisk Investigational Site Fishers Indiana 46038-1862 —
Novo Nordisk Investigational Site Franklin Indiana 46131 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Michigan City Indiana 46360 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Crestview Hills Kentucky 41017-3464 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Metairie Louisiana 70006-2930 —
Novo Nordisk Investigational Site Metairie Louisiana 70006 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site North East Maryland 21901 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Southfield Michigan 48034-7661 —
Novo Nordisk Investigational Site Southfield Michigan 48075 —
Novo Nordisk Investigational Site Troy Michigan 48098 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site Kansas City Missouri 64111 —
Novo Nordisk Investigational Site Saint Charles Missouri 63303 —
Novo Nordisk Investigational Site Henderson Nevada 89052-2649 —
Novo Nordisk Investigational Site Las Vegas Nevada 89102 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Flemington New Jersey 08822-5763 —
Novo Nordisk Investigational Site Toms River New Jersey 08753-2975 —
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site The Bronx New York 10461 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Asheboro North Carolina 27203 —
Novo Nordisk Investigational Site Asheville North Carolina 28801 —
Novo Nordisk Investigational Site Burlington North Carolina 27215 —
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Shelby North Carolina 28152 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103 —
Novo Nordisk Investigational Site Canton Ohio 44718 —
Novo Nordisk Investigational Site Cincinnati Ohio 45224 —
Novo Nordisk Investigational Site Cincinnati Ohio 45242-4494 —
Novo Nordisk Investigational Site Cincinnati Ohio 45242 —
Novo Nordisk Investigational Site Cleveland Ohio 44113 —
Novo Nordisk Investigational Site Columbus Ohio 43213 —
Novo Nordisk Investigational Site Franklin Ohio 45005 —
Novo Nordisk Investigational Site Kettering Ohio 45429 —
Novo Nordisk Investigational Site Mason Ohio 45040-6815 —
Novo Nordisk Investigational Site Maumee Ohio 43537 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Bridgeville Pennsylvania 15017 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15235 —
Novo Nordisk Investigational Site East Providence Rhode Island 02914 —
Novo Nordisk Investigational Site Columbia South Carolina 29201-2970 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Pelzer South Carolina 29669 —
Novo Nordisk Investigational Site Simpsonville South Carolina 29681 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Taylors South Carolina 29687 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site DeSoto Texas 75115 —
Novo Nordisk Investigational Site Fort Worth Texas 76113 —
Novo Nordisk Investigational Site Houston Texas 77004-7000 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Houston Texas 77095 —
Novo Nordisk Investigational Site Irving Texas 75061-2210 —
Novo Nordisk Investigational Site Killeen Texas 76543-5600 —
Novo Nordisk Investigational Site Lubbock Texas 79423 —
Novo Nordisk Investigational Site San Antonio Texas 78215 —
Novo Nordisk Investigational Site San Antonio Texas 78224 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Ogden Utah 84403 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Burke Virginia 22015 —
Novo Nordisk Investigational Site Manassas Virginia 20110 —
Novo Nordisk Investigational Site Newport News Virginia 23606 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23462 —
Novo Nordisk Investigational Site Spokane Washington 99208 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 156 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01336023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2018 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01336023 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →